Answers are grounded in this paper and cite their sources.
Shows Lactiplantibacillus plantarum TH-B59 enhances DNA repair in response to UVB, suggesting probiotic therapy may mitigate skin cancer risk.
Ultraviolet B (UVB) exposure initiates skin carcinogenesis by generating persistent DNA photolesions and immunosuppressive microenvironment. Whether a defined probiotic can reinforce genome maintenance while counteracting UVB-driven inflammatory–checkpoint programs remains unclear. Here we show that oral administration of Lactiplantibacillus plantarum TH-B59 accelerates cyclobutane pyrimidine dimers (CPDs) resolution and dampens γ-H2AX accumulation in UVB-irradiated BALB/c skin. TH-B59 restores the expression of nucleotide excision repair–related genes ( Xpc , Ercc4 , Xpa , and Ercc5 ) and attenuates UVB-induced PI3K/AKT signaling. In parallel, TH-B59 suppresses UVB-induced NF-κB/COX-2/PGE 2 activation, reduces PD-L1 induction, and enhances IL-12 transcription, consistent with a shift toward immune surveillance. Fecal microbiota profiling identifies UVB-associated dysbiosis and a TH-B59–linked microbiome reconfiguration, with integrative correlation/network analyses connecting L. plantarum abundance to increased NER gene expression and reduced inflammatory mediators across gut and skin. Whole-genome sequencing supports TH-B59 as a bacteriocin-encoding, stress-tolerant strain lacking transferable antibiotic resistance and virulence determinants. Collectively, TH-B59 couples photolesion clearance with inflammatory–checkpoint remodeling to mitigate early UVB programs that drive photocarcinogenesis.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: